SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

Irish MEP: “We have opened a can of worms that EFSA and the Commission would have much preferred remained closed”

3 commentsBy Shane Starling , 08-Mar-2012
Last updated on 09-Mar-2012 at 16:44 GMT2012-03-09T16:44:59Z

Irish MEP: “We have opened a can of worms that EFSA and the Commission would have much preferred remained closed”
Irish MEP: “We have opened a can of worms that EFSA and the Commission would have much preferred remained closed”
Loading the player...

Irish MEP Marian Harkin has become one of the most vocal European parliamentary opponents of the interpretation and application of the EU nutrition and health claims regulation (NHCR), and she was not appeased by EC and EFSA statements at a specially convened parliamentary meeting in Brussels yesterday.

There Harkin pointed to a clause in the NHCR she said indicated different types of claims (article 14 disease risk factor reduction versus article 13 general function claims for example) should be treated with differing scientific criteria, as UK nutritionist professor David Richardson indicated in his presentation at the event.

But the European Commission’s Health and Consumers Directorate (DG Sanco) representative, Basil Mathioudakis, flatly rejected Harkin’s implication, reaffirming the EC guidance that the European Food Safety Authority (EFSA) treat all health claim submissions equally in a scientific sense.

Speaking afterwards, Harkin expressed her frustration at the perceived stonewalling of what she said is clearly written in ‘recital 26’ of the 2006 regulation.

“No I was not happy with the answers I received because I voted for this regulation and as a legislator I expect the intent of the legislation to be carried through by the Commission and EFSA," she said.

“If you look at recital 26 the intent of the parliament is very clear. Recital 26 says that health claims other than those referring to the reduction of disease risk and children’s development and health based on generally accepted scientific evidence should undergo a different type of assessment and authorisation.”

Tsunami

Harkin reasoned a unified application of scientific criteria may have simplified dossier assessment for EFSA’s NDA health claims panel.

“I understand EFSA have a big problem,” she said. “I understand they were absolutely snowed under with the number of claims. It was like a tsunami hitting them so therefore they left the same level of assessment for all claims yet that was never intended by the legislator.”

“We have opened a can of worms that EFSA and the Commission would have much preferred remained closed.”

Harkin added that the day had delivered another “bombshell” when Mathioudakis admitted retail staff may be liable to prosecution if they give nutritional advice to customers on banned claims, but that enforcement was the responsibility of individual member state authorities.

Minefield

The Irish MEP, who is a member of the Alliance of Liberals and Democrats for Europe, was unimpressed by Mathioudakis’s suggestion that retailers could employ certain “tricks” to convey nutrient-health messaging such as the use of newspaper articles in-store.

“Is that we are asking food operators to resort to? This is a minefield,” she warned. “It will be impossible to implement and it is only by turning a blind eye that many of those shops can continue to operate. We cannot let a piece of legislation like this emerge with the parliament’s consent because we are the last line – right now – that can say yes or no to this.”

The NHCR text containing recital 26 can be found here.

3 comments (Comments are now closed)

Its not EFSA's fault

EFSA had to follow the instructions given by the EC. Therefore, the type of assessment of 13.1 claims was not chosen by EFSA and they cannot be blamed for harsh evaluation criteria of 13.1 claims.

Secondly, the unfair part, in my view, was the "applying of two different kinds of measures" for 13.1 claims: the vitamins/minerals claims were accepted based on text book knowledge, whereas other nutrients were evaluated based on intervention studies, although text book knowledge exists for them.

Many vitamins and minerals would have not won claims based on gold standard clinical trial evidence. To a great extent, the evidence for vit/mins resulted from deficiency epidemics. Ethically, such conditions cannot be used in todays clinical trial settings.

Hence, many 13.1 claims were evaluated as described in Art 15-18 and others were not.

In conclusion, I do not think that the evaluation of the 13.1 claims was consistent.

Report abuse

Posted by Dr. Christiane Alexander
19 March 2012 | 11h432012-03-19T11:43:49Z

Different assessment for Art.13 of botanicals HC now needed

I believe that in the prism of this denunciation of such misbehavior by EFSA EC will finally instruct them to adopt the different scientific criteria for the assessment of remaining more than 1500 botanicals claims that were "put on hold", comprising also the traditions of use.

Report abuse

Posted by Dr Vaclav Bazata
09 March 2012 | 12h092012-03-09T12:09:19Z

can of worms

health claims MUST be scientifically proven. Perhaps the methods to obtain proof may be less stringent (e.g. proof of principle, consensus based) but general statements based on "that is what I heared" or "that is what "they" say", is insufficient.

Report abuse

Posted by Frank Comhaire
08 March 2012 | 16h482012-03-08T16:48:24Z

Related products

Overcoming the taboo of vaginal health – the next frontier of probiotics

Overcoming the taboo of vaginal health – the next frontier of probiotics

A paradigm shift is needed to force delicate women’s health issues like vaginal infections...

FiE 2015: Our best bits

FiE 2015: Our best bits

Our teams of journalists were out in force at Food Ingredients Europe (FiE) last...

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New technology like crowdsourcing and artificial intelligence computers is the future of risk assessment,...

EFSA’s Bernhard Url: Science should reserve one private room for open debate

EFSA’s Bernhard Url: Science should reserve one private room for open debate

Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become...

Seadragon sets out to breathe fire into Kiwi fish oil

Seadragon sets out to breathe fire into Kiwi fish oil

The town of Nelson will welcome New Zealand's first omega-3 fish oil processing plant...

The taste test: How do you make a probiotic drink taste good?

The taste test: How do you make a probiotic drink taste good?

Probiotic fruit drinks face different challenges to their dairy counterparts - but both face...

African probiotic project reaching 10,000 infants a day

African probiotic project reaching 10,000 infants a day

Professor Gregor Reid

Chair , University of Western Ontario & Human Microbiology and...

Germvangelist set to shake Probiota with holistic shout

Germvangelist set to shake Probiota with holistic shout

Jason Tetro

Researcher, author, The Germ Guy

Creepy proteins will be hot

New proteins are creeping on trend

Alternative proteins are a “hot area” of interest and products such as sandwich spreads...

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Jake Riddle

General manager, Kerry Asia Pacific

Probiota Insights: Is a probiotic EFSA claim possible?

Probiota Insights: Is a probiotic EFSA claim possible?

We've seen hundreds of rejections in the past 10 years. But industry remains bullish...

Probiota Insights: What have the last five years taught us about probiotics?

Probiota Insights: What have the last five years taught us about probiotics?

There has been a revolution in technology. But what do we now know about...

Can prebiotics rival drugs for exercise-induced asthma?

Can prebiotics rival drugs for exercise-induced asthma?

Dr Neil Williams

Lecturer in Exercise Physiology and Nutrition, Nottingham Trent University

All mouth and some action: Oral probiotics still in infancy but promise is there

All mouth and some action: Oral probiotics still in infancy but promise is there

Dr Mette Kristine Keller

Assistant Professor , University of Copenhagen

Making a deposit: Faecal biobanks have ‘great potential’

Making a deposit: Faecal biobanks have ‘great potential’

Dr Tom Van de Wiele

Associate Professor, Ghent University

VIDEO: Meet Ms Ugene, the state-of-the-art Singapore robot testing TCM and food products

VIDEO: Meet Ms Ugene, the state-of-the-art Singapore robot testing TCM and food products

No errors, no mood swings, no sick leave, and she can process three sets...

Probiota Insights: Does the prebiotic definition need reworking?

Probiota Insights: Does the prebiotic definition need reworking?

Professor Bob Rastall

University of Reading

 ketone research attracts  elite sportspeople teams

'20 to 30 elite sportspeople/teams' involved in ketone research

Kieran Clarke

Professor of physiological biochemistry, University of Oxford

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars